financetom
Business
financetom
/
Business
/
Under Armour beats quarterly sales estimates amid turnaround efforts
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Under Armour beats quarterly sales estimates amid turnaround efforts
May 26, 2025 6:35 AM

(Reuters) -Under Armour ( UAA ) on Tuesday posted a smaller-than-expected drop in fourth-quarter revenue, helped by the sportswear maker's efforts to streamline its product lines that drove improved sales.

The Maryland-based retailer has been attempting to reset its business to reverse last year's sales slump by focusing on full-price sale of its products, lower promotions, inventory and workforce reductions.

The company's quarterly revenue fell 11% to $1.18 billion from a year ago, compared with analysts' average estimate of a 12.4% drop to $1.17 billion, according to data compiled by LSEG.

The company, however expects revenue for the current quarter to decline 4% to 5%, compared with analysts' expectations of a 1.9% fall, according to data compiled by LSEG.

It also refrained from providing an annual forecast, citing uncertainty surrounding trade policies and the macroeconomic environment, including potential demand-related and cost impacts from tariffs.

(Reporting by Neil J Kanatt and Savyata Mishra in Bengaluru; Editing by Shinjini Ganguli)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Syndax Pharmaceuticals Stock Falls After Data From Mid-Stage Study Of Revumenib In Form Of Blood Cancer
Syndax Pharmaceuticals Stock Falls After Data From Mid-Stage Study Of Revumenib In Form Of Blood Cancer
Nov 12, 2024
On Tuesday, Syndax Pharmaceuticals Inc ( SNDX ) revealed topline results from the relapsed or refractory (R/R) mutant NPM1 (mNPM1) acute myeloid leukemia (AML) cohort in the pivotal Phase 2 portion of the AUGMENT-101 trial of revumenib. The cohort met the primary endpoint with a complete remission (CR) plus CR with a partial hematological recovery (CRh) rate of 23% among the...
Long-time CEO of NEOM goes as Saudi Arabia scales back mega-projects
Long-time CEO of NEOM goes as Saudi Arabia scales back mega-projects
Nov 12, 2024
By Nayera Abdallah and Pesha Magid DUBAI/RIYADH (Reuters) -Nadhmi al-Nasr, the long-time chief executive of the $500 billion NEOM mega-project at the heart of Saudi Arabia's drive to diversify away from oil, has departed, NEOM said on Tuesday without giving a reason. Crown Prince Mohammed bin Salman, known as MbS, has poured hundreds of billions of dollars into development projects...
Marriott International Insider Sold Shares Worth $567,783, According to a Recent SEC Filing
Marriott International Insider Sold Shares Worth $567,783, According to a Recent SEC Filing
Nov 12, 2024
02:51 PM EST, 11/12/2024 (MT Newswires) -- William P Brown, Group President, US and Canada, on November 08, 2024, sold 2,037 shares in Marriott International ( MAR ) for $567,783. Following the Form 4 filing with the SEC, Brown has control over a total of 30,724 shares of the company, with 30,724 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1048286/000122520824009862/xslF345X05/doc4.xml Price: 286.79,...
Brazil's StoneCo posts adjusted profit beat in third quarter
Brazil's StoneCo posts adjusted profit beat in third quarter
Nov 12, 2024
SAO PAULO, Nov 12 (Reuters) - Brazilian payments firm StoneCo ( STNE ) posted on Tuesday a 35% increase in its third-quarter adjusted net profit from a year earlier, beating analysts' estimates. StoneCo ( STNE ), which also owns software and credit businesses, reported an adjusted net profit of 587 million reais ($101.7 million) for the quarter ended in September,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved